P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNA-34 (miR-34) is a direct target of p53, known for its tumor-suppressive functions.
• miR-34 mediates tumor suppression through cell cycle arrest, apoptosis, and metabolic regulation.
• The role of p53-mediated metabolic processes in cancer is significant, with several miR-34 targets identified.

Purpose of the Study:

• To review the current understanding of metabolic regulation by the p53/miR-34 axis.
• To explore the correlations among metabolic targets regulated by p53/miR-34.
• To propose future directions for developing metabolic approaches in anticancer therapy.

Main Methods:

• Literature review of studies on p53, miR-34, and metabolic regulation in cancer.
• Analysis of identified miR-34 targets involved in metabolic processes.
• Synthesis of current knowledge on the p53/miR-34 axis in cancer metabolism.

Main Results:

• The p53/miR-34 axis plays a crucial role in tumor suppression via cell cycle arrest and apoptosis.
• miR-34 influences cancer cell metabolism through various molecular targets.
• Interactions and correlations among these metabolic targets require further elucidation.

Conclusions:

• The p53/miR-34 axis is a key regulator of cancer metabolism with therapeutic potential.
• Understanding the metabolic regulatory network of p53/miR-34 is essential for targeted anticancer strategies.
• Metabolic interventions targeting the p53/miR-34 pathway offer promising avenues for cancer treatment.